| scholarly article | Q13442814 |
| P50 | author | Aris T. Papageorghiou | Q89154290 |
| P2093 | author name string | M Parra | |
| K H Nicolaides | |||
| C K H Yu | |||
| R Palma Dias | |||
| P2860 | cites work | A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies | Q28239787 |
| The Use of Low Dose Aspirin in Pregnancy | Q35177033 | ||
| Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials | Q40869082 | ||
| Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction | Q43744794 | ||
| The classification and definition of the hypertensive disorders of pregnancy | Q46254142 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| pre-eclampsia | Q61335 | ||
| randomized controlled trial | Q1436668 | ||
| maternal health | Q6786626 | ||
| P304 | page(s) | 233-9 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Ultrasound in Obstetrics and Gynecology | Q1817048 |
| P1476 | title | Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation | |
| P478 | volume | 22 |
| Q37639488 | Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis |
| Q26796661 | Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration |
| Q24245285 | Antiplatelet agents for preventing pre-eclampsia and its complications |
| Q24247721 | Antiplatelet agents for preventing pre-eclampsia and its complications |
| Q28211057 | Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data |
| Q34461435 | Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow |
| Q44029219 | Aspirin for pre-eclampsia: beware of subgroup meta-analysis |
| Q33822209 | Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial |
| Q38850828 | Aspirin vs Heparin for the Prevention of Preeclampsia |
| Q46056836 | Current controversies in prenatal diagnosis 4: pregnancy complications due to placental vascular disease (pre-eclampsia, FGR): are we ready for prevention? |
| Q46901141 | Electrochemical-surface enhanced Raman spectroscopy (E-SERS) of uric acid: a potential rapid diagnostic method for early preeclampsia detection |
| Q28195758 | Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis |
| Q27022333 | First- and second-trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta-analysis |
| Q37763163 | Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management |
| Q33875767 | Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths |
| Q36927599 | Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects |
| Q28167219 | Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making |
| Q37497808 | Internal iliac and uterine arteries Doppler ultrasound in the assessment of normotensive and chronic hypertensive pregnant women |
| Q26824714 | Low-Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta-Analysis |
| Q81446389 | Pre-eclampsia |
| Q35560414 | Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening |
| Q54280777 | Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks. |
| Q55062455 | Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks. |
| Q41587580 | Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks. |
| Q40472344 | Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19-24 weeks. |
| Q40443206 | Prophylactic treatment for preeclampsia in high-risk teenage primigravidae with nitric oxide donors: a pilot study |
| Q28168109 | Re: Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation |
| Q47831509 | Second-trimester uterine artery Doppler in the prediction of stillbirths. |
| Q37642835 | Short- and long-term strategies for the management of hypertensive disorders of pregnancy |
| Q50116335 | The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome |
| Q50623216 | Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial. |
| Q35756112 | Uterine artery Doppler flow studies in obstetric practice. |
Search more.